Deltex Medical Share Price | |
---|---|
Price | 0.12 |
Bid | 0.11 |
Ask | 0.13 |
Change | -0.005 (-4.00%) |
Volume | 76,788,882 |
Open | 0.13 |
High | 0.12 |
Low | 0.11 |
Prev. Close | 0.125 |
Currency | GBX |
---|---|
Issue Country | GB |
Shares in Issue | 1.90b |
Market Capitalisation | £2.28m |
Market Size | 300,000 |
52 Week High | 1.55 |
52 Week High Date | 15-May-2023 |
52 Week Low | 0.095 |
52 Week Low Date | 03-Apr-2024 |
# Trades | 20 |
---|---|
Vol. Sold | 20,376,340 |
Sold Value | £23.17k |
Vol. Bought | 7,408,702 |
Bought Value | £9.43k |
PE Ratio | -1.090909 |
Earnings | -0.11 |
Dividend | 0.00 |
Yield | 0.00% |
Date | Time | Trade Prc | Volume | Buy/Sell | Bid | Ask | Value | |
---|---|---|---|---|---|---|---|---|
08-May-24 | 13:29:11 | 0.11 | 8,503,840 | Unknown* | 0.11 | 0.13 | 9,354 | O Ordinary Delayed publication |
08-May-24 | 13:38:32 | 0.122 | 500,000 | Buy* | 0.11 | 0.13 | 610.00 | O Ordinary |
08-May-24 | 13:33:49 | 0.11 | 5,000,000 | Sell* | 0.11 | 0.13 | 5,500 | O Ordinary |
08-May-24 | 13:28:07 | 0.11 | 8,503,840 | Sell* | 0.11 | 0.13 | 9,354 | O Ordinary |
08-May-24 | 12:53:44 | 0.124 | 2,000,000 | Buy* | 0.11 | 0.13 | 2,480 | O Ordinary |
08-May-24 | 12:48:31 | 0.121 | 2,500,000 | Buy* | 0.11 | 0.13 | 3,025 | O Ordinary |
08-May-24 | 12:38:19 | 0.122 | 100,000 | Buy* | 0.11 | 0.13 | 122.00 | O Ordinary |
08-May-24 | 10:18:48 | 0.09 | 40,000,000 | Unknown* | 0.11 | 0.13 | 36.00k | O Ordinary Delayed publication |
08-May-24 | 11:10:46 | 0.11 | 1,000,000 | Sell* | 0.11 | 0.13 | 1,100 | UT Uncrossing Trade |
08-May-24 | 10:53:19 | 0.12 | 500,000 | Unknown* | 0.11 | 0.13 | 600.00 | O Ordinary |
Announced | Traded | Action | Notifier | Price | Currency | Amount | Holding |
---|---|---|---|---|---|---|---|
16-Jul-21 | 14-Jul-21 | Placing | Christopher Michael Jones held the position of Non-Executive Director at the time of this trade.Christopher Michael Jones | 1.75 | GBX | 1,371,429 | 4,297,291 |
16-Jul-21 | 14-Jul-21 | Placing | Nigel J Keen held the position of Chairman at the time of this trade.Nigel J Keen | 1.75 | GBX | 2,167,535 | 79,852,821 |
16-Jul-21 | 14-Jul-21 | Placing | Mark Wippell held the position of Non-Executive Director at the time of this trade.Mark Wippell | 1.75 | GBX | 1,371,429 | 10,237,875 |
16-Jul-21 | 14-Jul-21 | Placing | Charles Julian Cazalet held the position of Non-Executive Director at the time of this trade.Charles Julian Cazalet | 1.75 | GBX | 1,371,429 | 17,153,971 |
09-Feb-21 | 08-Feb-21 | Transfer To | Andy Mears held the position of CEO at the time of this trade.Andy Mears | 1.30 | GBX | 3,076,923 | 5,858,731 |
Leading fluid management and cardiac output monitoring systems. A single platform, TrueVue™ with ODM+, measuring flow and pressure directly.